Potential Failure of Novel-generation Oral Anticoagulants in Preventing Pulmonary Embolism: A Case Report and Current Literature Review-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Potential Failure of Novel-generation Oral Anticoagulants in Preventing Pulmonary Embolism: A Case Report and Current Literature Review

Published:2024-03-01 Issue:1 Volume:62 Page:51-53
ISSN:1302-0072
Container-title:Medical Bulletin of Haseki
language:
Short-container-title:Haseki

Author:

Bicen Asli^ORCID,Tural Onur Seda^ORCID,Tokgoz Akyil Fatma^ORCID,Kara Kaan^ORCID,Abali Hulya^ORCID,Boyraci Neslihan^ORCID,Kinik Betul^ORCID

Publisher

Galenos Yayinevi

Reference8 articles.

1. Epidemiology of venous thromboembolism;Heit;Nat Rev Cardiol,2015

2. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS): The Task Force for the diagnosis and management of acute pulmonary embolism of the European Society of Cardiology (ESC);Konstantinides;Eur Heart J,2020

3. Oral apixaban for the treatment of acute venous thromboembolism;Agnelli;N Engl J Med,2013

4. 4. Bavalia R, Bistervels IM, Boersma WG, et al. Quality of life in patients with pulmonary embolism treated with edoxaban versus warfarin. Res Pract Thromb Haemost 2021;5:e12566.

5. Oral rivaroxaban for the treatment of symptomatic pulmonary embolism;EINSTEIN-PE Investigators;N Engl J Med,2012

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3